FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2913740034> ?p ?o ?g. }

• W2913740034 abstract "To study the influence of blood lipid levels on hemorrhagic transformation (HT) and prognosis after acute cerebral infarction (ACI). Patients with ACI within 72 h of symptoms onset between January 1st, 2015, and December 31st, 2016, were retrospectively analyzed. Patients were divided into group A (without HT) and group B (HT). The outcomes were assessed after 3 months of disease onset using the modified Rankin Scale (mRS). An mRS score of 0–2 points indicated excellent prognosis, and an mRS score of 3–6 points indicated poor prognosis. A total of 732 patients conformed to the inclusion criteria, including 628 in group A and 104 in group B. The incidence of HT was 14.2%, and the median onset time was 2 d (interquartile range, 1–7 d). The percentages of patients with large infarct size and cortex involvement in group B were 80.8 and 79.8%, respectively, which were both significantly higher than those in group A (28.7 and 33.4%, respectively). The incidence rate of atrial fibrillation (AF) in group B was significantly higher than that in group A (39.4% vs. 13.9%, P < 0.001). The adjusted multivariate analysis results showed that large infarct size, cortex involvement and AF were independent risk factors of HT, while total cholesterol (TC) was a protective factor of HT (OR = 0.359, 95% CI 0.136–0.944, P = 0.038). With every 1 mmol/L reduction in normal TC levels, the risk of HT increased by 64.1%. The mortality and morbidity at 3 months in group B (21.2 and 76.7%, respectively) were both significantly higher than those in group A (8.0 and 42.8%, respectively). The adjusted multivariate analysis results showed that large infarct size (OR = 12.178, 95% CI 5.390–27.516, P < 0.001) was an independent risk factor of long-term unfavorable outcomes, whereas low-density lipoprotein cholesterol (LDL-C) was a protective factor (OR = 0.538, 95% CI 0.300–0.964, P = 0.037). With every 1 mmol/L reduction in normal LDL-C levels, the risk of an unfavorable outcome increased by 46.2%. Major therapies, including intravenous recombinant human tissue plasminogen activator (rTPA), intensive lipid-lowering statins and anti-platelets, were not significantly related to either HT or long-term, post-ACI poor prognosis. For patients with large infarct sizes, especially those with cortex involvement, AF, or lower levels of TC, the risk of HT might increase after ACI. The risk of a long-term unfavorable outcome in these patients might increase with a reduction in LDL-C." @default.
• W2913740034 created "2019-02-21" @default.
• W2913740034 creator A5000222441 @default.
• W2913740034 creator A5003799076 @default.
• W2913740034 creator A5027184836 @default.
• W2913740034 creator A5028369775 @default.
• W2913740034 creator A5030967805 @default.
• W2913740034 creator A5070187366 @default.
• W2913740034 creator A5075510757 @default.
• W2913740034 creator A5089926060 @default.
• W2913740034 date "2019-01-22" @default.
• W2913740034 modified "2023-10-15" @default.
• W2913740034 title "Influences of blood lipids on the occurrence and prognosis of hemorrhagic transformation after acute cerebral infarction: a case-control study of 732 patients" @default.
• W2913740034 cites W1525545408 @default.
• W2913740034 cites W1546258268 @default.
• W2913740034 cites W1856460279 @default.
• W2913740034 cites W1925357517 @default.
• W2913740034 cites W1968737649 @default.
• W2913740034 cites W1972179384 @default.
• W2913740034 cites W1998869669 @default.
• W2913740034 cites W2006647499 @default.
• W2913740034 cites W2012655589 @default.
• W2913740034 cites W2021665899 @default.
• W2913740034 cites W2045445343 @default.
• W2913740034 cites W2045852185 @default.
• W2913740034 cites W2051562207 @default.
• W2913740034 cites W2067395123 @default.
• W2913740034 cites W2079936483 @default.
• W2913740034 cites W2082559134 @default.
• W2913740034 cites W2088763244 @default.
• W2913740034 cites W2089254388 @default.
• W2913740034 cites W2131192729 @default.
• W2913740034 cites W2138595885 @default.
• W2913740034 cites W2146707618 @default.
• W2913740034 cites W2158528601 @default.
• W2913740034 cites W2164089346 @default.
• W2913740034 cites W2164698528 @default.
• W2913740034 cites W2164924348 @default.
• W2913740034 cites W2167574024 @default.
• W2913740034 cites W2170420840 @default.
• W2913740034 cites W2171165037 @default.
• W2913740034 cites W2175592470 @default.
• W2913740034 cites W2226142946 @default.
• W2913740034 cites W2293186471 @default.
• W2913740034 cites W2300281082 @default.
• W2913740034 cites W2460112936 @default.
• W2913740034 cites W2472906357 @default.
• W2913740034 cites W2525780151 @default.
• W2913740034 cites W2587471701 @default.
• W2913740034 cites W2598003106 @default.
• W2913740034 cites W2612483410 @default.
• W2913740034 cites W4297741748 @default.
• W2913740034 doi "https://doi.org/10.1186/s40779-019-0191-z" @default.
• W2913740034 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6341695" @default.
• W2913740034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30665465" @default.
• W2913740034 hasPublicationYear "2019" @default.
• W2913740034 type Work @default.
• W2913740034 sameAs 2913740034 @default.
• W2913740034 citedByCount "6" @default.
• W2913740034 countsByYear W29137400342020 @default.
• W2913740034 countsByYear W29137400342021 @default.
• W2913740034 countsByYear W29137400342022 @default.
• W2913740034 crossrefType "journal-article" @default.
• W2913740034 hasAuthorship W2913740034A5000222441 @default.
• W2913740034 hasAuthorship W2913740034A5003799076 @default.
• W2913740034 hasAuthorship W2913740034A5027184836 @default.
• W2913740034 hasAuthorship W2913740034A5028369775 @default.
• W2913740034 hasAuthorship W2913740034A5030967805 @default.
• W2913740034 hasAuthorship W2913740034A5070187366 @default.
• W2913740034 hasAuthorship W2913740034A5075510757 @default.
• W2913740034 hasAuthorship W2913740034A5089926060 @default.
• W2913740034 hasBestOaLocation W29137400341 @default.
• W2913740034 hasConcept C119060515 @default.
• W2913740034 hasConcept C120665830 @default.
• W2913740034 hasConcept C121332964 @default.
• W2913740034 hasConcept C126322002 @default.
• W2913740034 hasConcept C2777798775 @default.
• W2913740034 hasConcept C2779161974 @default.
• W2913740034 hasConcept C2779450755 @default.
• W2913740034 hasConcept C2780931571 @default.
• W2913740034 hasConcept C3020199598 @default.
• W2913740034 hasConcept C500558357 @default.
• W2913740034 hasConcept C50440223 @default.
• W2913740034 hasConcept C541997718 @default.
• W2913740034 hasConcept C61511704 @default.
• W2913740034 hasConcept C71924100 @default.
• W2913740034 hasConcept C90924648 @default.
• W2913740034 hasConceptScore W2913740034C119060515 @default.
• W2913740034 hasConceptScore W2913740034C120665830 @default.
• W2913740034 hasConceptScore W2913740034C121332964 @default.
• W2913740034 hasConceptScore W2913740034C126322002 @default.
• W2913740034 hasConceptScore W2913740034C2777798775 @default.
• W2913740034 hasConceptScore W2913740034C2779161974 @default.
• W2913740034 hasConceptScore W2913740034C2779450755 @default.
• W2913740034 hasConceptScore W2913740034C2780931571 @default.
• W2913740034 hasConceptScore W2913740034C3020199598 @default.
• W2913740034 hasConceptScore W2913740034C500558357 @default.
• W2913740034 hasConceptScore W2913740034C50440223 @default.
• W2913740034 hasConceptScore W2913740034C541997718 @default.
• W2913740034 hasConceptScore W2913740034C61511704 @default.

• next